Insights & Discussion
Concentrated pomegranate juice consumption can potentially lower cardiovascular disease risk factors in women with polycystic ovary syndrome.
The study used a randomized clinical approach, enrolling 44 women identified with polycystic ovary syndrome, aged 18 to 40 years and above a certain body weight index. These participants were randomly divided into two groups: one group was given concentrated pomegranate juice (CPJ), while the other served as a control. Both groups were monitored over a period of 8 weeks, with baseline measurements taken for anthropometric measures, blood pressure, and biochemical parameters set at the onset and then compared at the end of the trial.
Upon completion, the group that consumed CPJ showed reductions in blood pressure and serum triglyceride levels — a known risk factor for cardiovascular diseases. There was also an increase in the amount of high density lipoprotein-cholesterol (good cholesterol) and a decrease in the triglyceride to high-density lipoprotein-cholesterol ratio. However, an increase was observed in levels of low-density lipoprotein-cholesterol (bad cholesterol). No adverse events or complications arose from CPJ consumption during the study period.
Discover Related Insights
Pomegranate extract could potentially benefit women's reproductive health, enhance fertility, regulate menstrual cycles, support pregnancy, and help treat polycystic ovary syndrome.
2024 Life Therapeutic Potential of Pomegranate Extract for Women’s Reproductive Health and Breast Cancer Jang JY, Kim D, Im E, Kim ND
Breast Cancer PCOS Pomegranate
In establishing the potential benefits of pomegranate extract in women's reproductive health, a wide array of methods was employed. Primarily, these included in vitro studies, animal modeling and certain clinical trials. Analyses of the antioxidant properties of the extract were done to ascertain its effectiveness in reducing oxidative stress and consequently, improving fertility. The influence of pomegranate extract on hormonal imbalances and menstrual regulation was also studied.
Discussions on the results emphasized the potential of pomegranate extract in supporting women's reproductive health. The extract was found beneficial in enhancing fertility, regulating menstruation and supporting pregnancy. Further, it could help in polycystic ovary syndrome therapy by improving insulin sensitivity and reducing oxidative damage. Its rich nutrient composition was appreciated for potentially fostering placental development and fetal growth, thus possibly mitigating the risk of early birth. Apart from reproductive health, some studies pointed towards pomegranate extract's potential anticancer properties, primarily against breast cancer.
Pomegranate and its components could offer considerable potential as dietary supplements or supports in treatment for cardiovascular and non-cardiovascular diseases.
2023 Antioxidants An Overview of the Health Benefits, Extraction Methods and Improving the Properties of Pomegranate Benedetti G, Zabini F, Tagliavento L, Meneguzzo F, Calderone V, Testai L
Review Article Cardiovascular Disease Pomegranate
The review examines a myriad of recent preclinical and clinical studies focusing on pomegranate. To harness the health benefits of pomegranate, different components were extracted and studied. These include juice from the fruit's edible arils, oil from the seeds, and bioactive products from the typically discarded peel. The research also considers advances in encapsulation and green extraction techniques to optimize the use of waste pomegranate products.
The studies suggest promising beneficial effects of pomegranate in diverse areas. Though challenges remain, such as limited oral bioavailability and uncertainty concerning the role of active metabolites, the collective findings offer crucial insight into the significant potential of pomegranate as a dietary supplement or co-therapy for a range of diseases, especially cardiovascular and non-cardiovascular ones.
Pomegranate juice extract may reduce the damage to the endometrium in Polycystic ovary syndrome through its antioxidant, anti-inflammatory, anti-fibrotic, and anti-proliferative effects.
2022 Morphologie Role of pomegranate extract in restoring endometrial androgen receptor expression, proliferation, and pinopodes in a rat model of polycystic ovary syndrome Ibrahim MAA, Sadek MT, Sharaf Eldin HEM
Experimental Study Endometrium PCOS Pomegranate
To test the possible benefits of pomegranate juice extract (PJE) on endometrial injury in Polycystic ovary syndrome (PCOS), forty adult albino rats were divided into four groups, control, PJE-treated, letrozole-treated (PCOS), and PJE & PCOS groups. The respective treatments were administered for a duration of three weeks. Serum and tissue samples were assayed for Follicle-stimulating hormone, Luteinizing hormone, testosterone, estradiol, and malondialdehyde. Uterine samples were also tested using a range of histological staining techniques and a scanning electron microscope.
In the rat model of PCOS, significant increases in certain biochemical indicators in serum samples were observed while uterine sections showed numerous alterations to the endometrium, signs of inflammation and an increase in the endometrial collagen fiber content. Additionally, there was increased expression of certain immunohistochemical staining markers and a decrease in the mean number of pinopodes observed through scanning electron microscopy. However, these various potentially harmful biochemical, histological and immunohistochemical alterations were efficiently reduced with the administration of PJE. This points towards the potential benefits of PJE in addressing and potentially reducing endometrial injury associated with PCOS.
Pomegranate extract consumption improves antioxidant levels, reduces oxidative stress and cardiovascular risk factors including blood pressure and body fat, and increases lean body mass.
2022 Antioxidants Antioxidant Properties and Beneficial Cardiovascular Effects of a Natural Extract of Pomegranate in Healthy Volunteers: A Randomized Preliminary Single-Blind Controlled Study Al-Dujaili EAS, Casey C, Stockton A
Randomised Controlled Trial Cardiovascular Disease High Blood Pressure Pomegranate
In the study, 24 healthy participants were divided into two groups: one consumed a natural standardized pomegranate extract, while the other, a placebo, in a randomized, single-blind placebo-controlled trial. Evaluations were conducted at baseline and post 14 and 28 days of the experiment, with variables including anthropometric measurements, blood pressure, pulse wave speed, body composition, as well as the levels of salivary and urinary cortisol, cortisone, total phenolics, antioxidant capacity, and lipid peroxidation.
The results indicated significant increases in urinary total phenolics excretion and antioxidant capacity after 14 and 28 days of pomegranate extract intake. By day 28, notable decreases were noted in systolic and diastolic blood pressure, pulse wave velocity, body fat and fat mass, and an increase in lean body mass. In terms of glucocorticoid levels, there was a marked decrease in saliva cortisol at day 28 in the morning for the pomegranate extract group, along with a decrease in the cortisol/cortisone ratio following 28 days of pomegranate extract intake at morning, noon, and evening. Reductions were also seen in urine free cortisol levels by day 14. These observations were unique to the pomegranate extract group, with no significant changes noted in the placebo group.
The pomegranate plant has a rich inventory of phytochemical constituents showing pharmacological efficiency in treating cardiovascular and endocrine diseases.
2021 Journal of Nutrition and Metabolism Therapeutic Effects of Punica granatum (Pomegranate): An Updated Review of Clinical Trials Eghbali S, Askari SF, Avan R, Sahebkar A
Review Article Anticancer Cardiovascular Disease Oral Health
The researchers set out to review both traditional and scientific applications of P. granatum focusing on its phytochemical content and potential for aiding in drug development. They gathered relevant information through both classic herbal literature and electronic databases, which included renowned platforms such as PubMed, Scopus, and ScienceDirect.
The culmination of traditional and contemporary research showed an array of phytochemical constituents in P. granatum, including polyphenolics, flavonoids, anthocyanosides, alkaloids, lignans, and triterpenes. Randomized controlled trials indicated these constituents demonstrate pharmacological activity, particularly against diseases like diabetes, cardiovascular disease, oral cavity disorders, endocrine disorders, and even cancer. The review, therefore, not only points to the traditional uses of P. granatum but underscores their validation through scientific support.
Sign In
Users not signed in are limited to viewing the 5 most recent items of content.